Acción A102940 KOLON LIFE SCIENCE INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Kolon Life Science Inc.

Acciones

A102940

KR7102940004

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 21/05/2024 		Varia. Cinco días. Varia. 1 de enero.
22.100 KRW +2,08 % Gráfico intradía de Kolon Life Science Inc. -1,12 % -14,01 %
20/03 Kolon Life Science Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI
2023 Kolon Life Science Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 2.0068 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Kolon Life Science Inc.(KOSDAQ:A102940) added to S&P Global BMI Index
Kolon Life Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kolon Biotech, Inc. announced that it has received KRW 5.112 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 5.112 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kolon Biotech, Inc. announced that it expects to receive KRW 994 million in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 1.5 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 1.005 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Kolon Biotech, Inc. announced that it expects to receive KRW 2.511 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Kolon Biotech, Inc. announced that it expects to receive KRW 2.499 billion in funding from Kolon Life Science Inc.
Kolon Life Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Kolon Biotech, Inc. announced that it has received KRW 5.562 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it expects to receive KRW 5.562 billion in funding from Kolon Life Science Inc.
Kolon Biotech, Inc. announced that it has received KRW 5.06 billion in funding from Kolon Life Science Inc.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A102940
  4. Noticias Kolon Life Science Inc.
  5. Otros idiomas
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA